首站-论文投稿智能助手
典型文献
The novel BRDT inhibitor NHWD870 shows potential as a male contraceptive in mice
文献摘要:
Small molecule inhibitors of the bromodomain and extraterminal domain(BET)family proteins have emerged as promising options not only for the treatment of multiple cancers but also for disturbing the process of sperm maturation with potential for use as viable contraceptive targets.In this study,we find that the BET family inhibitor NHWD870 and BRDT can bind well in vitro through bioinformatics software prediction and protein binding in-hibition experiments.NHWD870 can produce a good contraceptive effect through animal experiments in vivo,and the fertility can be restored to normal after drug withdrawal.Transcriptomics and proteomics results suggest that NHWD870 affects pathways related to spermatogenesis and maturation,further contributing to the male infertility phenotype.Our results show that NHWD870 can induce a complete and reversible contraceptive effect in mice,which is stronger than that of JQ1 and its synthesized derivatives.This study is expected to eventually lead to clinical trials.
文献关键词:
作者姓名:
Sixian Wu;Xiaoliang Li;Lijun Shang;Lvying Wu;Tongtong Li;Peiyv Li;Zhiliang Ji;Jianwen Hou;Mingzhu Yin;Wenming Xu
作者机构:
Joint Laboratory of Reproductive Medicine,SCU-CUHK,Key Laboratory of Obstetric,Gynaecologic and Paediatric Diseases and Birth Defects of Ministry of Education,West China Second University Hospital,Sichuan University,Chengdu 610041,China;Reproductive Medical Centre,West China Second University Hospital,Sichuan University,Chengdu 610041,China;School of Human Sciences,London Metropolitan University,London N7 8BD,UK;State Key Laboratory of Cellular Stress Biology,School of Life Sciences,Xiamen University,Xiamen 361102,China;Department of Dermatology,Hunan Engineering Research Center of Skin Heath and Disease,Xiangya Hospital,Central South University,Changsha 410008,China
引用格式:
[1]Sixian Wu;Xiaoliang Li;Lijun Shang;Lvying Wu;Tongtong Li;Peiyv Li;Zhiliang Ji;Jianwen Hou;Mingzhu Yin;Wenming Xu-.The novel BRDT inhibitor NHWD870 shows potential as a male contraceptive in mice)[J].生物化学与生物物理学报(英文版),2022(12):1789-1800
A类:
BRDT,NHWD870,extraterminal
B类:
novel,shows,potential,as,male,contraceptive,mice,Small,molecule,inhibitors,bromodomain,BET,family,proteins,have,emerged,promising,options,only,treatment,multiple,cancers,also,disturbing,process,maturation,use,viable,targets,In,this,study,find,that,well,vitro,through,bioinformatics,software,prediction,binding,hibition,experiments,produce,good,effect,animal,vivo,be,restored,normal,after,drug,withdrawal,Transcriptomics,proteomics,results,suggest,affects,pathways,related,spermatogenesis,further,contributing,infertility,phenotype,Our,induce,complete,reversible,which,stronger,than,JQ1,its,synthesized,derivatives,This,expected,eventually,lead,clinical,trials
AB值:
0.561774
相似文献
EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription
Xiaoqing Lu;Liwei An;Guangjian FanTi;Lijuan Zang;Weiyi Huang;Junjian Li;Jun Liu;Weiyu Ge;Yuwei Huang;Jingxuan Xu;Shaoqian Du;Yuan Cao;Tianhao Zhou;Huijing Yin;Li Yu;Shi Jiao;Hongxia Wang-State Key Laboratory of Oncogenes and Related Genes,Department of Oncology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Breast Surgery,Shanxi Cancer Hospital,Chinese Academy of Medical Sciences,Taiyuan,Shanxi,China;Department of Medical Ultrasound,Shanghai Tenth People's Hospital,Tongji University Cancer Center,School of Medicine,Tongji University,Shanghai,China;Precision Research Center for Refractory Diseases,Institute for Clinical Research,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Pathology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;State Key Laboratory of Membrane Biology,Tsinghua-Peking University Joint Center for Life Sciences,School of Life Science,Tsinghua University,Beijing,China;State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai,China
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Yi Xiao;Ding Ma;Yun-Song Yang;Fan Yang;Jia-Han Ding;Yue Gong;Lin Jiang;Li-Ping Ge;Song-Yang Wu;Qiang Yu;Qing Zhang;Francois Bertucci;Qiuzhuang Sun;Xin Hu;Da-Qiang Li;Zhi-Ming Shao;Yi-Zhou Jiang-Key Laboratory of Breast Cancer in Shanghai,Department of Breast Surgery,Fudan University Shanghai Cancer Center;Department of Oncology,Shanghai Medical College,Fudan University,Shanghai,China;Human Phenome Institute,Fudan University,Shanghai,China;Department of Pathology,University of Texas Southwestern Medical Center,Dallas,TX,USA;Predictive Oncology team,Centre de Recherche en Cancérologie de Marseille(CRCM),INSERM UMR1068,CNRS UMR725,Aix-Marseille Université,Institut Paoli-Calmettes,Marseille,France;Department of Industrial Systems Engineering and Management,National University of Singapore,Singapore,Singapore
Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway
Xu-xia Li;Peng Zhang;Yang Yang;Jing-jing Wang;Yan-jun Zheng;Ji-liang Tan;Shen-yan Liu;Yong-ming Yan;You-yi Zhang;Yong-xian Cheng;Huang-tian Yang-CAS Key Laboratory of Tissue Microenvironment and Tumor,Laboratory of Molecular Cardiology,Shanghai Institute of Nutrition and Health,University of Chinese Academy of Sciences,CAS,Shanghai 200031,China;State Key Laboratory of Phytochemistry and Plant Resources in West China,Kunming Institute of Botany,CAS,Kunming 650201,China;Department of Cardiology and Institute of Vascular Medicine,Peking University Third Hospital;NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides;Key Laboratory of Molecular Cardiovascular Science,Ministry of Education,Beijing Key Laboratory of Cardiovascular Receptors Research,Beijing 100191,China;School of Pharmaceutical Sciences,Health Science Center,Shenzhen University,Shenzhen 518060,China;Department of Cardiology,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Shanghai 200233,China;Institute for Stem Cell and Regeneration,CAS,Beijing 100101,China
Pharmacodynamic,pharmacokinetic,and phase 1a study of bisthianostat,a novel histone deacetylase inhibitor,for the treatment of relapsed or refractory multiple myeloma
Yu-bo Zhou;Yang-ming Zhang;Hong-hui Huang;Li-jing Shen;Xiao-feng Han;Xiao-bei Hu;Song-da Yu;An-hui Gao;Li Sheng;Ming-bo Su;Xiao-li Wei;Yue Zhang;Yi-fan Zhang;Zhi-wei Gao;Xiao-yan Chen;Fa-jun Nan;Jia Li;Jian Hou-National Center for New Drug Screening,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Yantai Key Laboratory of Nanomedicine&Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China;Department of Hematology,Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200127,China;Shanghai Center for Drug Metabolism and Pharmacokinetics Research,Shanghai 201203,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis
Ying Dong;Bi-xi Tang;Qi Wang;Li-wei Zhou;Cong Li;Xuan Zhang;Dan-dan Sun;Xin Sun;Xue-mei Zhang;Bing Xiong;Jia Li;Hong Shi;Dan-qi Chen;Yi Zang-State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Pharmacology,School of Pharmacy,Fudan University,Shanghai 201203,China;Department of Medicinal Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Center for Supramolecular Chemistry and Catalysis and Department of Chemistry,College of Sciences,Shanghai University,Shanghai 200444,China;Schoolof Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing 210023,China;Schoolof Pharmacy,Henan University,Kaifeng 475004,China;Open Studio for Druggability Research of Marine Natural Products,Pilot National Laboratory for Marine Science and Technology(Qingdao),Qingdao 266237,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,UCAS,Hangzhou 310024,China;Department of Anesthesiology of Shanghai Pulmonary Hospital,School of medicine,Tongji University,Shanghai 200433,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。